Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma

Published:2004-06 Issue:6 Volume:10 Page:386-394
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Van Besien Koen,Mehra Rakesh,Wadehra Navin,Stock Wendy,Khouri Issa,Giralt Sergio,Devine Steve,Wickrema Amittha,Peace David,Sosman Jeff,Gajewski Jim,Champlin Richard

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference60 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma;Philip;N Engl J Med,1995

2. Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival;van Besien;Bone Marrow Transplant,2001

3. Autologous and allogeneic transplantation for aggressive NHL;Smith;Cytotherapy,2002

4. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin’s lymphoma;Smalley;N Engl J Med,1992

5. Alpha interferon in non-Hodgkin’s lymphoma—an update of the ECOG I-COPA trial;Smalley;Blood,1998

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Interleukin-2 Loaded Chitosan-Based Nanogels Using Artificial Neural Networks and Investigating the Effects on Wound Healing in Rats;AAPS PharmSciTech;2016-11-16

2. Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas;Leukemia & Lymphoma;2010-05-24

3. A Randomized Controlled Multicenter Study Comparing Recombinant Interleukin 2 (rIL-2) in Conjunction With Recombinant Interferon Alpha (IFN-α) Versus no Immunotherapy for Patients With Malignant Lymphoma Postautologous Stem Cell Transplantation;Journal of Immunotherapy;2010-04

4. IL-2 in the therapy of melanoma and other malignancies;Medical Oncology;2009-01

5. Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438);Blood;2008-04-15